Atara Biotherapeutics Announces Expanded Global Tab-cel Partnership With Pierre Fabre Laboratories And Third Quarter 2023 Financial Results; Cash, Cash Equivalents And Short-Term Investments As Of September 30, 2023, Totaled $102.4M
Benzinga Newsdesk - Nov 1, 2023, 8:34AM